Aims. There is evidence that morbidly obese patients have more intra- and postoperative complications and poorer outcomes when undergoing total hip arthroplasty (THA) with the direct anterior approach (DAA). The aim of this study was to determine the efficacy of DAA for THA, and compare the complications and outcomes of morbidly obese patients with nonobese patients. Methods. Morbidly obese patients (n = 86), with BMI ≥ 40 kg/m. 2. who underwent DAA THA at our institution between September 2010 and December 2017, were matched to 172 patients with BMI < 30 kg/m. 2. Data regarding demographics, set-up and operating time, blood loss, radiological assessment, Harris Hip Score (HHS), International Hip Outcome Tool (12-items), reoperation rate, and complications at two years postoperatively were retrospectively analyzed. Results. No significant differences in blood loss, intra- and postoperative complications, or implant position were observed between the two groups. Superficial wound infection rate was higher in the obese group (8.1%) compared to the nonobese group (1.2%) (p = 0.007) and relative risk of reoperation was 2.59 (95% confidence interval 0.68 to 9.91). One periprosthetic joint infection was reported in the obese group. Set-up time in the operating table and mean operating time were higher in morbidly obese patients. Functional outcomes and patient-related outcome measurements were superior in the obese group (mean increase of HHS was 52.19 (SD 5.95) vs 45.1 (SD 4.42); p < 0.001), and mean increase of International Hip Outcome Tool (12-items) was 56.8 (SD 8.88) versus 55.2 (SD 5.85); p = 0.041). Conclusion. Our results suggest that THA in morbidly obese patients can be safely and effectively performed via the DAA by experienced surgeons. Cite this article: Bone Jt Open 2022;3(1):4–11

Aims. We studied the outcomes of hip and knee arthroplasties in a high-volume arthroplasty centre to determine if patients with morbid obesity (BMI ≥ 40 kg/m. 2. ) had unacceptably worse outcomes as compared to those with BMI < 40 kg/m. 2. . Methods. In a two-year period, 4,711 patients had either total hip arthroplasty (THA; n = 2,370), total knee arthroplasty (TKA; n = 2,109), or unicompartmental knee arthroplasty (UKA; n = 232). Of these patients, 392 (8.3%) had morbid obesity. We compared duration of operation, anaesthetic time, length of stay (LOS), LOS > three days, out of hours attendance, emergency department attendance, readmission to hospital, return to theatre, and venous thromboembolism up to 90 days. Readmission for wound infection was recorded to one year. Oxford scores were recorded preoperatively and at one year postoperatively. Results. On average, the morbidly obese had longer operating times (63 vs 58 minutes), longer anaesthetic times (31 vs 28 minutes), increased LOS (3.7 vs 3.5 days), and significantly more readmissions for wound infection (1.0% vs 0.3%). There were no statistically significant differences in either suspected or confirmed venous thromboembolism. Improvement in Oxford scores were equivalent. Conclusion. Although morbidly obese patients had less favourable outcomes, we do not feel that the magnitude of difference is clinically significant when applied to an individual, particularly when improvement in Oxford scores were unrelated to BMI. Cite this article: Bone Jt Open 2021;2(7):515–521

Introduction. Morbid obesity (BMI>40) is a significant risk factor for complications following total joint arthroplasty (TJA). As such many have a restrictive practice of withholding elective primary TJA in the morbidly obese. The purpose of this study was to observe the implications of this practice. Methods. From 2012 to 2014, 289 patients with morbid obesity and end-stage OA of the hip or knee were prospectively followed. At initial visit, patients were given a packet on risks of TJA in the morbidly obese and referral information to a weight loss clinic. Patients were contacted at 6, 12, 18 and 24 months from initial visit for PROs, and BMI changes. The average age of patients was 56 (26.7–79.1) there were 218 females and 71 males. Results. The average BMI at initial visit was 46.9 (39.9–68.2). 85 patients (29%) refused additional follow up or to answer phone surveys regarding their status. 146 patients (50.5%) have not had surgery. Initial BMI in this cohort was 47.4 (39.9–68.6) and at last follow up was 46.8 (28.9–70.8). Of those, 11 (7.5%) had a last follow up BMI≤40. Only 23% of patients went to the bariatric clinic and 13% had bariatric surgery. Fifty-eight patients (20.1%) underwent TJA. BMI at initial visit was 45.3 (40.3–55.4), and at the time of surgery was 41.3 (27.5–69.5). Only 20 patients (6.9% of those followed) have successfully achieved BMI < 40 and had surgery. Of those, 14 (70%) had a last follow up BMI≤40, and 2 (10%) had a last follow up BMI≤30. Conclusions. The practice of restricting total joint replacement to morbidly obese patients does not serve as an incentive to lose weight prior to arthroplasty. Only 20% of patients ultimately underwent TJA and the majority of those remained morbidly obese. Better resources and collaborative care among specialties is required to optimize patients prior to surgery

Aims. Obesity is associated with an increased risk of hip osteoarthritis, resulting in an increased number of total hip arthroplasties (THAs) performed annually. This study examines the peri- and postoperative outcomes of morbidly obese (MO) patients (BMI ≥ 40 kg/m. 2. ) compared to healthy weight (HW) patients (BMI 18.5 to < 25 kg/m. 2. ) who underwent a THA using the anterior-based muscle-sparing (ABMS) approach. Methods. This retrospective cohort study observes peri- and postoperative outcomes of MO and HW patients who underwent a primary, unilateral THA with the ABMS approach. Data from surgeries performed by three surgeons at a single institution was collected from January 2013 to August 2020 and analyzed using Microsoft Excel and Stata 17.0. Results. This study compares 341 MO to 1,140 HW patients. Anaesthesia, surgery duration, and length of hospital stay was significantly lower in HW patients compared to MO. There was no difference in incidence of pulmonary embolism, periprosthetic fracture, or dislocation between the two groups. The rate of infection in MO patients (1.47%) was significantly higher than HW patients (0.14%). Preoperative patient-reported outcome measures (PROMs) show a significantly higher pain level in MO patients and a significantly lower score in functional abilities. Overall, six-week and one-year postoperative data show higher levels of pain, lower levels of functional improvement, and lower satisfaction scores in the MO group. Conclusion. The comorbidities of obesity are well studied; however, the implications of THA using the ABMS approach have not been studied. Our peri- and postoperative results demonstrate significant improvements in PROMs in MO patients undergoing THA. However, the incidence of deep infection was significantly higher in this group compared with HW patients. Cite this article: Bone Jt Open 2023;4(5):299–305

Introduction. Rapid recovery protocols after joint replacement have been implemented widely to decrease hospital length of stay (LOS). Minimally-invasive total knee arthroplasty (MIS-TKA) may facilitate rapid recovery for patients. Increased complications and LOS have been documented in morbidly obese TKA patients. The objective of the current study was to retrospectively evaluate the impact of morbid obesity on MIS-TKA patients. Methods. We conducted a retrospective chart review on patients that underwent MISTKA at a high volume orthopedic center between August 2012 and September 2015 (N = 4173). All surgeries were performed by one of six fellowship trained surgeons utilizing the same implant. MISTKA was performed utilizing a mid-vastus approach under tourniquet. All patients experienced rapid recovery protocols utilizing multi-modal pain management pathways, same day physical therapy, and absence of CPM machines. We evaluated patient age, gender, operative time, LOS, and 90-day readmission for morbidly obese (BMI≥40; n = 597), and non-morbidly obese (BMI<40; n = 3576) patients. Statistical analysis was conducted using Minitab 16 Statistical Software. Results. Morbidly obese patients had significantly higher mean LOS (1.74 days) compared to non-morbidly obese patients (1.62 days, p=0.035), and significantly higher 90-day readmissions (12.45% and 6.65% respectively, p= 0.001). In patients over the age of 65, with BMI under 40, females had significantly higher mean LOS than males (1.70 and 1.47 days respectively, p< 0.001). And in non-morbidly obese patients under the age of 65, females still experienced significantly higher mean LOS compared to males (1.35 and 1.11 days respectively, p<0.001). Conclusions. Our findings indicate that despite implementation of rapid recovery protocols, morbidly obese patients experienced significantly higher LOS than non-morbidly obese patients. Compared to their male counterparts, non-morbidly obese female patients had significantly higher LOS

Abstract. Aims. The association between body mass index (BMI) and venous thromboembolism (VTE) is well studied, but remains unclear in the literature. We aimed to determine whether morbid obesity (BMI≥40) was associated with increased risk of VTE following total knee arthroplasty (TKA) or unicompartmental knee arthroplasty (UKA), compared to those of BMI<40. Methods. Between January 2016 and December 2020, our institution performed 4506 TKAs and 449 UKAs. 450 (9.1%) patients had a BMI≥40. CT pulmonary angiography (CTPA) for suspected pulmonary embolism (PE) and ultrasound scan for suspected proximal deep vein thrombosis (DVT) were recorded up to 90 days post-operatively. Results. When comparing those of BMI<40 to those with BMI≥40, there was no difference in incidence of PE (1.0% vs 1.1%, p=0.803) or proximal DVT (0.4% vs 0.2%, p=0.645). There was no difference in number of ultrasound scans ordered (p=0.668), or number of CTPAs ordered for those with a BMI≥40 (p=0.176). The percentage of patients with a confirmed PE or proximal DVT were 24.2% and 3.9% respectively in the BMI<40 group, compared to 20.0% (p=0.804) and 2.3% (p=0.598) in the BMI≥40 group. Conclusion. Morbid obesity was not associated with increased risk of PE or proximal DVT within 90 days of TKA or UKA. Overall, 76.3% of CTPAs and 96.2% of ultrasound scans were negative. Increasing the threshold for VTE investigation would reduce the rate of negative investigations. Establishing more effective risk stratification protocols, to guide investigation, would likely reduce unnecessary imaging

Purpose: Displaced acetabular fractures require operative intervention for optimal results. Obesity and morbid obesity is becoming more prevalent. Morbid obesity is defined as a body-mass index (BMI) > 40. The purpose of this investigation is to evaluate the early results of operative treatment of acetabular fractures in morbidly obese patients. Method: A prospectively gathered database demonstrated 349 patients who underwent ORIF for acetabular fractures over a 60 month period. Of those patients, 39 were morbidly obese. Patient weights were collected from anesthesia records. There were 15 posterior wall, 10 transverse/posterior wall, 5 T-type, 3 transverse, 3 anterior column/posterior hemi-transverse, 1 anterior column, 1 posterior column/posterior wall, and 1 both column fractures. Early results of morbidly obese patients (Group 1) were reviewed. Perioperative complications were compared to patients with BMI < 40 (Group 2). Factors evaluated were: estimated blood loss, operative time, length of hospital stay, and overall complication rate (as defined by wound complications or heterotopic ossification requiring subsequent surgery, failure of fixation, nerve palsy, death). Results: Follow up ranged from 6–48 months. Fracture reductions were perfect in 23, imperfect in 10, and poor in 6. Fixation failure was noted in 9 patients and typically associated with comminuted posterior wall fractures. Eight patients developed deep infections necessitating debridements. Nine patients required secondary surgery for wound healing problems. Of those, 6 required one additional surgery, three required 2, two required 3, one required 5, and one required 12 additional surgeries. Six patients proceeded to THA and two of those required revisions. The average EBL was 903cc in group 1 versus 630cc in group 2 (p < 0.044). Operative time averaged 293 minutes in group 1 versus 250 in group 2 (p< 0.008). Hospital stay for group 1 averaged 26 days versus 15 days in group 2 (p< 0.008). Complication rate for group 1 was 67% versus 16% in group 2. Conclusion: This data shows that there is a significant increase in estimated blood loss, operative time, and length of hospital stay. Moreover, the risk of complications should be heavily weighed prior to operative intervention

Background:. The rising number of morbidly obese patients may have significant consequences on the health care system. It may alter the effectiveness, safety as well as cost of certain surgical procedures. Reverse shoulder arthroplasty (RSA) is rapidly gaining in popularity. We investigated the effect of morbid obesity on outcomes, complications, disposition and cost in morbidly obese patients undergoing RSA in a 1: 3 case control series. Methods:. Our joint registry was searched for all patients undergoing primary RSA (excluding fractures) with a minimum of 24 months follow-up from 2003–2010; 21 patients with Body Mass Index (BMI) > 35 were identified (follow-up 45 ± 16 months, 17 females and 4 males, age 69 ± 7) and compared to 63 matched control patients with BMI<30 (follow-up 48 ± 20, 50 females, age 71 ± 6). Outcome data was obtained pre- and postoperatively. Patients' Charlson-Deyo comorbidity index (CDI), total comorbidities, operative time, blood loss (EBL), hospitalization length, disposition, cost and complications were recorded. Results:. There were significant (p < 0.05 for all) and comparable improvements in clinical outcomes, i.e. ASES 32→69 versus 40→78) and range-of-motion (i.e. elevation 61°→140° versus 74°→153°). Obese patients had less notching (1/21 versus 5/63, p = 0.007). Obese patients had more total comorbidities excluding obesity (6 versus 4, p = 0.001), higher CDI (2 versus 1, p = 0.025) and higher rates of obstructive sleep apnea (48% versus 3%, p = 0.0001). They had longer operative time by 13 minutes (p = 0.014) and higher EBL by 40 ml (p = 0.008). Length of stay was similar (3.1 versus 2.6 days, p = 0.21) but a 6-fold higher rate of discharge to facilities (6/21 versus 3/63, p = 0.007) and a higher readmission rate (2 versus 0, p = 0.06) was seen in obese patients. Hospital cost was higher by $2,958.00 (p = 0.02). Major (n = 4 versus 8) and minor complication rates (n = 3 versus 14) were similar (p = 0.479 and 0.440, respectively). No intraoperative complications or mechanical device failures were noted in either group. Conclusions:. RSA was as safe and effective in morbidly obese patients, but an increased cost, disposition to facilities and needs after discharge was observed

Purpose: The increasing trend of morbidly obese patients (BMI 40+) requiring joint replacement is becoming a growing concern in Total Hip Replacement (THR) surgery. The purpose of this study was to investigate the influence that BMI may have on implant longevity and clinical outcome using prospectively collected patient data. Method: A consecutive cohort of 2864 THR’s in 2488 patients with osteoarthritis and a minimum 2 years follow-up were evaluated. Patients were divided into appropriate BMI categories; Normal and Underweight (BMI< 25, n=650), Overweight (BMI 25–29.9, n=1069), Obese (BMI 30–39.9, n=981), and Morbidly Obese (BMI 40+, n=164). Pre-operative, latest, and change in clinical outcome scores (HSS, SF12, WOMAC) were analyzed using ANOVA and Kaplan-Meier (K-M) survivorship was determined. Categorical variables such as gender and survival status were analyzed using chi-squared. Results: Morbidly Obese patients requiring THR’s were significantly younger than all other BMI groups by 5.4±0.83 years (p< 0.0001). Gender was also significant to BMI grouping with more females being Morbidly Obese and Normal or Underweight (p< 0.0001). All pre-operative and latest HHS and WOMAC domain scores were lower for the Morbidly Obese, significantly in all preoperative score domains and latest HHS Function (p< 0.05). The change in clinical scores from pre-operative to latest was greatest in all domains for the Morbidly Obese group. K-M cumulative survival with implant revision as the endpoint at 10 years was not different between the BMI groups. Revision rates for infection for the Morbidly Obese, Obese, Overweight, and Normal were 1.3%, 0.65%, 0.3% and 0.69% respectively. Overall Revision rates for the Morbidly Obese, Obese, Overweight, and Normal were 6.7%, 5.4%, 6.9% and 5.7% respectively and were not found to be significant (p=0.496). Conclusion: The Morbidly Obese cohort undergoing THR had significantly lower preoperative and lower postoperative clinical outcome scores than all other BMI groups but demonstrated the most significant improvement. No difference was found in the K-M survivorship although revisions and revisions for infection were not equal between the groups

Aims

This study aims to evaluate the impact of metabolic syndrome in the setting of obesity on in-hospital outcomes and resource use after total joint replacement (TJR).

The purpose of this population-based study was to determine the association between morbid obesity and 10-year mortality and complications in patients undergoing primary THA. A cohort study of 22,251 patients, aged 45–74 years old, treated with primary THA between 2002 and 2007 for osteoarthritis, was conducted using Ontario administrative healthcare databases. Patients were followed for 10 years. Risk ratios (RRs) of mortality, reoperation, revision, and dislocation in patients with body mass index (BMI) > 45 kg/m2(morbidly obese patients) compared with BMI ≤45 kg/m2 (non-morbidly obese) were estimated. 3.3% of the cohort (726) was morbidly obese. Morbidly obese patients were younger (mean age 60.6 vs. 63.3, P-value < 0 .001) and more likely to be female (63.9% vs. 52.2%, P-value < 0 .001), compared with non-morbidly obese patients. Morbid obesity was associated with higher 10-year risk of death (RR 1.38, 95% CI 1.18, 1.62). Risks of revision (RR 1.43, 95% CI 0.96, 2.13) and dislocation (RR 2.38, 95% CI 1.38, 4.10) were higher in morbidly obese men, compared with non-morbidly obese men, there were no associations between obesity and revision or dislocation in women. Risk of reoperation was higher in morbidly obese women, compared to non-morbidly obese women (RR 1.60, 95% CI 1.05, 2.40), there was no association between obesity and reoperation in men. Morbidly obese patients undergoing primary THA are at higher risks of long-term mortality and complications. There were differences in complication risk by sex. Results should inform evidence-based perioperative counseling of morbidly obese patients considering THA

To describe the longitudinal trends in patients with obesity and Metabolic Syndrome (MetS) undergoing TKA and the associated impact on complications and lengths of hospital stay. We identified patients who underwent primary TKA between 2006 – 2017 within the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database. We recorded patient demographics, length of stay (LOS), and 30-day major and minor complications. We labelled those with an obese Body Mass Index (BMI ≥ 30), hypertension, and diabetes as having MetS. We evaluated mean BMI, LOS, and 30-day complication rates in all patients, obese patients, and those with MetS from 2006-2017. We used multivariable regression to evaluate the trends in BMI, complications, and LOS over time in all patients and those with MetS, and the effect of BMI and MetS on complication rates and LOS, stratified by year. 270,846 patients underwent primary TKA at hospitals participating in the NSQIP database. 63.71% of patients were obese (n = 172,333), 15.21% were morbidly obese (n = 41,130), and 12.37% met criteria for MetS (n = 33,470). Mean BMI in TKA patients increased at a rate of 0.03 per year (0.02-0.05; p < 0 .0001). Despite this, the rate of adverse events in obese patients decreased: major complications by an odds ratio (OR) of 0.94 (0.93-0.96; p < 0 .0001) and minor complications by 0.94 (0.93-0.95; p < 0 .001). LOS also decreased over time at an average rate of −0.058 days per year (-0.059 to −0.057; p < 0 .0001). The proportion of patients with MetS did not increase, however similar improvements in major complications (OR 0.94 [0.91-0.97] p < 0 .0001), minor complications (OR 0.97 [0.94-1.00]; p < 0 .0330), and LOS (mean −0.055 [-0.056 to −0.054] p < 0 .0001) were found. In morbidly obese patients (BMI ≥ 40), there was a decreased proportion per year (OR 0.989 [0.98-0.994] p < 0 .0001). Factors specifically associated with major complications in obese patients included COPD (OR 1.75 [1.55-2.00] p < 0.0001) and diabetes (OR 1.10 [1.02-1.1] p = 0.017). Hypertension (OR 1.12 [1.03-1.21] p = 0.0079) was associated with minor complications. Similarly, in patients with MetS, major complications were associated with COPD (OR 1.72 [1.35-2.18] p < 0.0001). Neuraxial anesthesia was associated with a lower risk for major complications in the obese cohort (OR 0.87 [0.81-0.92] p < 0.0001). BMI ≥ 40 was associated with a greater risk for minor complications (OR 1.37 [1.26-1.50] p < 0.0001), major complications (1.11 [1.02-1.21] p = 0.015), and increased LOS (+0.08 days [0.07-0.09] p < 0.0001). Mean BMI in patients undergoing primary TKA increased from 2006 - 2017. MetS comorbidities such as diabetes and hypertension elevated the risk for complications in obese patients. COPD contributed to higher rates of major complications. The obesity-specific risk reduction with spinal anesthesia suggests an improved post-anesthetic clinical course in obese patients with pre-existing pulmonary pathology. Encouragingly, the overall rates of complications and LOS in patients with obesity and MetS exhibited a longitudinal decline. This finding may be related to the decreased proportion of patients with BMI ≥ 40 treated over the same period, possibly the result of quality improvement initiatives aimed at delaying high-risk surgery in morbidly obese patients until healthy weight loss is achieved. These findings may also reflect increased awareness and improved management of these patients and their elevated risk profiles

Aim. To compare the results of total knee replacement in a consecutive series of morbidly obese patients (body mass index (BMI) > 40 kg/m. 2. ) with a matched group of non-obese (BMI< 30 kg/m. 2. ) patients. Methods. 41 consecutive total knee replacements performed in morbidly obese patients were matched pre-operatively with 41 total knee replacements performed in non-obese patients for age, sex, diagnosis, type of prosthesis, laterality, knee score and function score components of the Knee Society Score (KSS). All patients were prospectively followed up and the post-operative KSS, radiographs, complications (superficial wound infection, deep joint infection, deep venous thrombosis, peri-operative mortality) and five-year survivorship compared for the two groups. No patients were lost to follow-up (mean follow-up in morbidly obese: 38.5 (range 6-66) months; non-obese: 44 (range 6-67) months). Results. The mean knee score was inferior in the morbidly obese group compared to the non-obese group, but the difference only approached significance (p=0.08). The mean function score was significantly inferior in the morbidly obese group compared to the non-obese group (p=0.01). Total knee replacements performed in morbidly obese patients were associated with a significantly higher incidence of radiolucent lines on post-operative radiographs (29% vs. 7%, p=0.02) and a significantly higher complication rate (32% vs. 0%, p=0.001). The five-year survivorship based on revision and pain as endpoints was 72.3% (95% Confidence Interval (CI) 52.1%-92.5%) for the morbidly obese group compared to 97.6% (95% CI 92.9%-100%) for the non-obese group (log-rank test, p = 0.02). Conclusion. In a subgroup of obese patients who are morbidly obese, the results of total knee replacement are poor. These patients should be advised to lose weight prior to surgery or be warned of the inferior results before proceeding with surgery

Background. Tranexamic acid (TXA) is a lysine analog that has been shown to reduce intra-operative blood loss in total joint replacements. Effect of TXA in morbid obese patients has not been established. The aim of this study was to evaluate the effect of TXA on change of haematocrit (HCT) and packed RBC (PRBC) blood transfusion rate in our institution, especially in morbid obese patients. Methods. Between January 2014 and December 2014, 216 primary and revision hip and knee arthroplasty were identified from our prospective institutional database. All cases were performed by two adult reconstruction specialists. All primary total hip arthroplasties (THA) were non-cemented and all primary total knee arthroplasties (TKA) were cemented with similar implant and technique. Use of TXA in our institution was initiated on August of 2014. TXA was given intravenously (IV) as one gram prior to incision and one gram at the time of femoral preparation in THA or cementation in TKA, not exceeding 10mg/kg. In cases where IV TXA was contraindicated, topical was used. We analyzed pre- and post-operative hematocrit and transfusion rate. Criteria for transfusion was HCT < 25 or Hb < 9. 72 patients (33%) were considered morbid obese with body mass index (BMI) ≥ 35. Results. In the non-TXA group, 50 out of 126 cases (40%) were transfused (17 THA, 25 TKA, 5 revision THA, 3 revision TKA), ranging from 1–5 PRBC. In the TXA group, 13 out of 90 cases (14%) were transfused (3 THA, 8 TKA, 2 revision THA), ranging 1–2 PRBC. This difference was statistically significant (p=0.0001). The overall drop in the TXA group HCT was 5.9 ± 3.9, as compared to 9.8 ± 4.3 in the non-TXA groups, which was statistically significant (p=0.0001). The mean pre- and post-operative HCT was 37.4 ± 4.3 and 28.2 ± 3 in the transfused patients without TXA. The average drop in HCT was 9.3 ± 4.3. The mean pre- and post-operative HCT was 34.3 ± 4.1 and 27.4 ± 1.9 in the transfused patients without TXA. The average drop in HCT was 7.3 ± 2.9. In the morbid obese patients, 45 did not receive TXA, 17 had transfusion with average drop in HCT of 9.6 ± 3.9; 29 received TXA and 2 had transfusion with average drop in HCT of 5.9 ± 3.1. There transfusion and drop in HCT was significantly less for morbid obese patients that received TXA (p=0.0001). Discussion and Conclusions. Since initiating TXA in our institution, the overall transfusion rate in both primary and revision arthroplasty cases have dramatically declined (26%). This was more evident in morbidly obese patients. In cases that needed transfusion with TXA, only one or two PRBC was given, which was a drastic improvement

Obesity is clearly a worldwide epidemic with significant social, health care and economic implications. A clear association between obesity and the need for both hip and knee replacement surgery has been demonstrated. Specifically the presence of class 3 obesity (BMI > 40) increases the incidence of THA by 8.5 times and the incidence of TKA by 32.7 times, compared with patients of normal weight. Issues related to TJA in the morbidly obese include:. Outcomes - There is a growing body of evidence to support the premise that patients undergoing either THA or TKA who are morbidly obese derive significant benefit from the surgical intervention. Specifically patient and disease specific outcome measures (WOMAC, SF-12, KSCRS, HSS) demonstrate equal change between pre-operative and post-operative scores in those patients of normal weight compared to the morbidly obese cohort. Complications - It would appear that the rate of deep infection is increased in the morbidly obese, and that the greater the BMI, the greater the risk of infection. This is important to understand and appreciate pre-operatively as the surgeon discusses the risk/benefit ratio of the operative intervention. There is little debate that performing total joint arthroplasty in the morbidly obese is technically challenging and that the potential for increased peri-operative morbidity, particularly in the form of infection is present. That being said, the realised benefit to the patient of the surgical intervention is significant, and denying surgery on the basis of obesity alone is not justified

Introduction. Perioperative optimization efforts have improved outcomes following primary total knee arthroplasty (TKA). However, morbidly obese patients continue to have increased rates of complications. The purpose of this study was to assess if rates of early complications after TKA have similarly improved for both morbidly obese and non-morbidly obese patients. Methods. Elective, primary TKA patients from 2011–2018 were identified in the National Surgical Quality Improvement Program database. Patients were stratified by body mass index (BMI) <40 kg/m. 2. and ≥40 kg/m. 2. Thirty-day rates of infectious complications, readmissions, and reoperation were assessed. Trends in these endpoints over the study period were compared between BMI groups utilizing odds ratios (OR) and multivariate analyses. Results. In total, 314,719 patients underwent TKA and 46,386 (15%) had BMI ≥40 kg/m. 2. From 2011–2018, the reoperation rate significantly improved from 1.2% to 1.0% (OR: 0.6 [0.6–0.7]) for patients with BMI <40 kg/m. 2. , as did rates of readmission (4.5% to 2.9%, OR: 0.8 [0.7–0.99]). Patients with BMI ≥40 kg/m. 2. also had a significant decrease in the rate of readmission over the study period (4.9% to 3.3%, OR: 0.6 [0.5–0.8]); however, the rate of reoperation did not significantly change (1.4% to 1.4%, OR: 1.0 [0.6–1.6]). Significant improvements were not observed for infectious complications over time for either group. However, patients with BMI ≥40 kg/m. 2. consistently had increased risk of both deep infection from 2014–2018 (2014 OR: 2.2 [1.4–3.4], 2018: 2.2 [1.6–3.0]) and wound complications from 2011–2018 (2011 OR: 1.7 [1.2–2.6], 2018 OR: 2.0 [1.7–2.4]) compared to non-morbidly obese patients. Conclusion. Although readmission rates significantly decreased for all patients, improvements in reoperation rates observed in non-morbidly obese patients were not experienced by the morbidly obese – resulting in a widening of the complication gap between these cohorts. Care improvements have not lowered the differential risk of infectious complications compared to non-morbidly obese

Obesity is clearly a worldwide epidemic with significant social, healthcare and economic implications. A clear association between obesity and the need for both hip and knee replacement surgery has been demonstrated. Specifically the presence of class 3 obesity (BMI > 40) increases the incidence of THA by 8.5 times, and the incidence of TKA by 32.7 times, compared with patients of normal weight. Issues related to TJA in the morbidly obese include: Outcomes - There is a growing body of evidence to support the premise that patients undergoing either THA or TKA who are morbidly obese derive significant benefit from the surgical intervention. Specifically patient and disease specific outcome measures (WOMAC, SF-12, KSCRS, HSS) demonstrate equal change between preoperative and postoperative scores in those patients of normal weight compared to the morbidly obese cohort; Complications - It would appear that the rate of deep infection is increased in the morbidly obese, and that the greater the BMI, the greater the risk of infection. This is important to understand and appreciate preoperatively as the surgeon discusses the risk/benefit ratio of the operative intervention. There is little debate that performing total joint arthroplasty in the morbidly obese is technically challenging and that the potential for increased perioperative morbidity, particularly in the form of infection is present. That being said, the realised benefit to the patient of the surgical intervention is significant, and denying surgery on the basis of obesity alone is not justified

Introduction and Aims: Morbid obesity (BMI> 40) has been shown to cause increased perioperative morbidity and poorer long-term implant survivorship following total knee arthroplasty (TKA). The aim of this study was to determine the impact of morbid obesity on patient-reported outcomes following TKA. Methods: Patients undergoing primary TKA were invited to complete questionnaires preoperatively and one year after surgery. Questionnaires include the WOMAC and SF-36 health status measures, demographics, self-reported comorbid medical conditions, height and weight. At follow-up, satisfaction with results of TKA is included. Patients were categorised by their preoperative BMI categories as ideal weight (20–25), overweight (> 25–30), obese (> 30–40) or morbidly obese (> 40). We used multivariate analysis to adjust for known significant correlates of WOMAC and SF-36, namely age, gender and comorbid medical conditions. Adjusted mean scores for each assessment were compared by BMI category. Results: A total of 769 patients were included in the study which included 27 morbidly obese, 280 obese, 314 overweight and 148 ideal weight patients. Morbidly obese patients when compared with non-obese patients had significantly worse preoperative WOMAC pain and function and a trend for worse SF36 scores (Vitality significantly worse, p=0.04). There was no significant difference between the BMI categories at one year for WOMAC or SF-36 scores (trend for the Physical Functioning score to be lower, p=0.052). Morbidly obese patients were all satisfied with pain relief after surgery but were less satisfied with functional results when compared to the non-obese groups. Discussion: This study shows that morbidly obese patients report significantly worse health status prior to TKA but their post-operative improvement is greater than the non-obese population. Although morbid obesity should not be an absolute contraindication to TKA, patients should be carefully selected balancing the risk of perioperative complications and earlier failure against the demonstrated marked improvement in quality of life

Introduction. Given the association of osteoarthritis with obesity, the typical patient requiring total knee arthroplasty (TKA) is often obese. Obesity has been shown to negatively influence outcomes following TKA, as it is associated with increased perioperative complications and poorer clinical and functional outcomes. Achieving proper limb alignment can be more difficult in the obese patient, potentially requiring a longer operation compared to non-obese patients. Patient specific instrumentation (PSI), a technique that utilizes MR- or CT-based customized guides for intraoperative cutting block placement, may offer a more efficient alternative to manual instruments for the obese patient. We hypothesize that the additional information provided by a preoperative MRI or CT may allow surgeons to achieve better alignment in less time compared to manual instrumentation. The purpose of this study was to assess whether PSI offers an improved operation length or limb alignment compared to manual instruments for nonmorbidly and morbidly obese patients. Methods. In this retrospective cohort study, we evaluated 77 PSI TKA and 25 manual TKA performed in obese patients (BMI≥30) between February 2013 and May 2015. During this period, all patients underwent PSI TKA unless unable to undergo MR scanning. All cases were performed by a single experienced surgeon and utilized a single implant system (Zimmer Persona™). PSI cases were performed using the MR-based Zimmer Patient Specific Instrumentation system. Tourniquet times were recorded to determine length of operation. Long-standing radiographs were obtained preoperatively and 4-weeks postoperatively to evaluate limb alignment. Cases were subdivided by nonmorbid obesity (30≤BMI<40) and morbid obesity (BMI≥40) to assess the effect of increasing obesity on outcomes. Results. PSI and manual cohorts were similar with regards to age, gender, and preoperative alignment. Tourniquet time was significantly shorter in the PSI group for nonmorbidly obese patients (PSI 49.8 minutes vs manual 58.3 minutes; p=0.005) (Figure 1). Postoperative mechanical axis was similar between groups for both nonmorbidly obese (PSI 1.8° vs manual 2.9°; p=0.338) and morbidly obese patients (PSI 4.0° vs manual 3.6°; p=0.922). Mechanical axis outliers (greater than 3° neutral), though nonsignificant, were fewer in the PSI group for nonmorbidly obese (PSI 21.8% vs manual 35.3%; p=0.318) and morbidly obese patients (PSI 46.1% vs manual 75.0%; p=0.362). Discussion. We found that PSI significantly shortened operation length for nonmorbidly obese patients compared to manual instruments. Obesity is strongly associated with increased perioperative infection rates, as is prolonged operation length. The decreased operation length achieved with PSI in the nonmorbidly obese patient may as a consequence decrease infection rates, though further study is necessary. Though not statistically significant, PSI showed a trend toward decreasing overall mechanical axis outliers for both nonmorbidly obese and morbidly obese patients. The use of patient specific instrumentation compared to manual instruments has been controversial in the literature. However, patient specific instrumentation may be favorable in the obese patient, offering a shorter operation length and possibly improved alignment

Obesity and the diseases linked to it such as diabetes have been associated with higher complication rates and increased medical costs following total hip arthroplasty (THA). Due to the rising prevalence of obesity and the adverse impact it has on the development of osteoarthritis, there has been a worldwide surge in the number of obese patients presenting for THA procedures, including those morbidly obese (BMI > 40) and those who are super-obese (BMI > 50). The Reward. When THA is successful (as is true for the majority of morbidly obese patients) the operation is just as dramatically effective as it is for other patients. Excellent pain relief and dramatically improved function is the result, even though obese patients generally achieve a lower overall level of function than non-obese patients. Morbidly obese patients with a successful THA and without early complications are some of the most grateful of patients. This is especially true if they have been denied surgery for prolonged periods due to their weight and have had to bear severe joint changes and symptoms during a long period of time leading up to arthroplasty. The Risks. There is a nonlinear increase in complications, reoperations, and especially infection with increasing BMI that begins between a BMI of 25 to 30, and rises thereafter with a relative inflection point in some incidence curves for complications at around a BMI of 40. This has caused some surgeons to suggest a BMI of 40 as an upper limit for elective hip arthroplasty. Risks continue to rise after a BMI of 40 and when the BMI is over 50, in our series 52% of patients had at least one complication. Of these 24% had at least one major complication and 33% at least one minor complication with some suffering more than one complication overall. These data make it reasonable to ask whether the outcomes in some morbidly obese patients might be improved by weight loss, bariatric surgical intervention and other measures aimed at optimizing the multiple companion comorbidities and medical conditions (such as diabetes) that often accompany excess weight. Unfortunately there has been limited information to date on the best means for optimizing of these patients, and as important the effectiveness of these interventions, so that the timing and performance of the eventual arthroplasty procedures might have the highest possible success rate. The Costs. The adverse impact of obesity on medical resource utilization and costs associated with THA has been well documented, Due to longer initial length of stay, greater resource utilization, higher early complication rates and any readmissions and reoperations the costs for even a single individual patient can climb dramatically. In a review of data on primary THA patients from our institution, even after adjusting for age, sex, type of surgery, and other comorbidities, for every 5 unit increase in BMI beyond 30 kg/m2 there was an associated $500 higher cost of hospitalization and an increase of $900 in 90-day total costs (p=0.0001). The Future. The numbers of morbidly obese patients with severe osteoarthritis presenting for possible THA will only continue to increase in the years ahead. Comprehensive multidisciplinary programs are urgently needed to better manage obese patients with weight reduction options, optimization of medical comorbidities, and treatment of any associated issues, such as protein malnutrition. When end-stage joint changes and symptoms occur we must have such help to maximise the benefit and reduce the complications of hip arthroplasty in this high risk patient population